In episode 278, James and Mike get back to being PREMIUM podcasters and we discuss new studies around drugs for COPD, pneumonia, and smoking cessation. At the end we catch our breath and look back at how breathtaking this PREMIUM podcast all about lung issues truly was.
1) Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
2) Antibiotic treatment strategies for community-acquired pneumonia in adults.
N Engl J Med 2015;372:1312-23
3) Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis